Delivery of TFPI-2 using SonoVue and adenovirus results in the suppression of thrombosis and arterial re-stenosis

Experimental Biology and Medicine

Volumn 235, Issue 9, 2010, Pages 1072-1081

  Wang, Yuxue ^a   Zhou, Jie ^a   Zhang, Yanrong ^b   Wang, Ximing ^a   Chen, Juan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Atherosclerosis; Gene therapy; Microbubble ultrasound contrast agent; Re stenosis; Thrombosis; Tissue factor pathway inhibitor 2

Indexed keywords

CONTRAST MEDIUM; SONOVUE; TISSUE FACTOR PATHWAY INHIBITOR; CONTRAST AGENT BR1; GLYCOPROTEIN; PHOSPHOLIPID; SULFUR HEXAFLUORIDE; TISSUE-FACTOR-PATHWAY INHIBITOR 2;

ADENOVIRUS; ANIMAL EXPERIMENT; ARTERY INJURY; ARTERY OCCLUSION; ARTERY THROMBOSIS; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; BLOOD; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ENDOTHELIUM CELL; FEMALE; GENE FUNCTION; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROBUBBLE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RESTENOSIS; THROMBOSIS; ULTRASOUND; VASCULAR ENDOTHELIUM; ADENOVIRIDAE; ADENOVIRUS INFECTION; ARTERIOLE; GENETICS; METABOLISM;

ADENOVIRIDAE;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ARTERIOLES; GENETIC THERAPY; GLYCOPROTEINS; HUMANS; MICROBUBBLES; PHOSPHOLIPIDS; SULFUR HEXAFLUORIDE; THROMBOSIS; TRANSFECTION;

EID: 77957114717     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2010.010046     Document Type: Article

References (22)

1. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-74
2. Gregory Y, Lip H, Blann AD. Does hypertension confer a prothrombotic state? Virchow's triad revisited. Circulation 2000;101:218-20
3. Chappell JC, Song J, Burke CW, Klibanov AL, Price RJ. Targeted delivery of nanoparticles bearing fibroblast growth factor-2 by ultrasonic microbubble destruction for therapeutic arteriogenesis. Small 2008;10:1769-77
4. Lupu C, Hu X, Lupu F. Caveolin-1 enhances tissue factor pathway inhibitor exposure and function on the cell surface. J Biol Chem 2005;280:22308-17 (Pubitemid 40827887)
5. Gosk-Bierska I, Wysokin Ski W, Karnicki K, Adamiec R. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study. Int Angiol 2008;27:296-301
6. Xu Z, Maiti D, Kisiel W, Duh EJ. Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells. Arterioscler Thromb Vasc Biol 2006;26:2819-25
7. Qin S, Caskey CF, Ferrara KW. Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering. Phys Med Biol 2009;54:R27-57
8. Dijkmans PA, Juffermans LJM, Musters RJP, van Wamel A, ten Cate FJ, van Gilst W, Visser CA, de Jong N, Kamp O. Microbubbles and ultrasound: from diagnosis to therapy. Eur J Echocardiography 2004;5:245-56
9. Hallow DM, Mahajan AD, Prausnitz MR. Ultrasonically targeted delivery into endothelial and smooth muscle cells in ex vivo arteries. J Control Release 2007;118:285-93
10. Dayton PA, Zhao S, Bloch SH, Schumann P, Penrose K, Matsunaga TO, Zutshi R, Danikov A, Ferrara KW. Application of ultrasound to selectively localize nanodroplets for targeted imaging and therapy. Mol Imaging 2006;5:160-74
11. Wei XL, Lin L, Hou Y, Fu X, Zhang JY, Mao ZB, Yu CL. Construction of recombinant adenovirus co-expression vector carrying the human transforming growth factor-β1 and vascular endothelial growth factor genes and its effect on anterior cruciate ligament fibroblasts. Chin Med J 2008;121:1426-32
12. Liu GJ, Moriyasu F, Hirokawa T, Rexiati M, Yamada M, Imai Y. Expression of heat shock proterin 70 in rabbit liver after contrast-enhanced ultrasound and radiofrequency ablation. Ultrasound Med Biol 2009;36:78-85
13. + current. Yonsei Med J 2000;41:372-80
14. He YF, Zhang GM, Wang XH, Zhang H, Yuan Y, Li D, Feng ZH. Blocking programmed death-1 ligand-PD-1 interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue chemokine. J Immunol 2004;173:4919-28
15. Bekeredjian R, Chen S, Frenkel PA, Grayburn PA, Shohet RV. Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation 2003;108:1022-6
16. Gouëffic Y, Potter-Perigo S, Chan CK, Johnson PY, Braun K, Evanko SP, Wight TN. Sirolimus blocks the accumulation of hyaluronan (HA) by arterial smooth muscle cells and reduces monocyte adhesion to the ECM. Atherosclerosis 2007;195:23-30
17. Harada M, Toki Y, Numaguchi Y, Osanai H, Ito T, Okumura K, Hayakawa T. Prostacyclin synthase gene transfer inhibits neointimal formation in rat balloon-injured arteries without bleeding complications. Cardiovasc Res 1999;43:481-91 (Pubitemid 29356386)
18. Gosk-Bierska I, Adarniec R. The role of tissue factor pathway inhibitor (TFPI) in tbrombotic complications. Pol Arch Med Wewn 2005;114:792-8
19. Ivanciu L, Gerard RD, Tang H, Lupu F, Lupu C. Adenovirus-mediated expression of tissue factor pathway inhibitor-2 inhibits endothelial cell migration and angiogenesis. Arterioscler Thromb Vasc Biol 2007;27:310-6
20. Kaufmann BA, Wei K, Lindner JR. Contrast echocardiography. Curr Probl Cardiol 2007;32:51-96
21. Tang J, Li S, Li J, Zhang Y, Li X, Dong B, Shi H, Zhang G. Evaluation of the effect of protamine on human prostate carcinoma PC-3m using contrast enhanced Doppler ultrasound. J Urol 2003;170:611-4
22. Choi JJ, Pernot M, Brown TR, Small SA, Konofagou EE. Spatio-temporal analysis of molecular delivery through the blood-brain barrier using focused ultrasound. Phys Med Biol 2007;52:5509-30 (Pubitemid 350056681)